We are trying to find patients at the highest risk and treat them for a longer period of time.

However, the effect is moderate, and further studies in younger people and over longer periods of time are needed in order to demonstrate clinical usefulness.

We are the first, and we truly had to work for that. It's quite unusual. People are not given to adventures in our field. We've done it and we are very pleased.